Skip to main content
main-content

25-09-2017 | ESMO 2017 | Video

ESMO 2017: RANGE trial results

Daniel Petrylak outlines the RANGE trial results for use of ramucirumab in patients with advanced urothelial carcinoma.

Read the accompanying news story.

Please log in to get access to this content